| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/30/1996 | US5541204 Aryloxypropanolamine β 3 adrenergic agonists |
| 07/30/1996 | US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents |
| 07/30/1996 | US5541195 1-acylpiperidine compounds |
| 07/30/1996 | US5541183 Ginkgolide derivatives |
| 07/30/1996 | US5541171 Orally administrable pharmaceutical composition |
| 07/30/1996 | US5541170 Orally administrable pharmaceutical compositions |
| 07/30/1996 | US5541168 Proteolytic enzyme inhibitors; degenerative diseases; respiratory, skin, genetic and gastrointestinal disorders; antiarrthritic and -inflammatory agents; genetic diseases |
| 07/30/1996 | US5541159 Calcitonin derivatives |
| 07/30/1996 | US5540917 Biomass lipase inhibitor useful for treating adiposity |
| 07/30/1996 | CA2027814C Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022295A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | WO1996022293A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | WO1996022292A1 Tricyclic vasopressin antagonists |
| 07/25/1996 | WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2210632A1 Tricyclic benzazepine vasopressin antagonists |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0722719A1 Process for preparing flavano-lignan preparations |
| 07/24/1996 | EP0722709A1 Fluoride releasing biomaterials |
| 07/24/1996 | EP0722438A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127508A Fused benzazepine derivative and pharmaceutical composition containing the same |
| 07/24/1996 | CN1127301A A method for the resolution of a racemic mixture of nucleoside enantioners |
| 07/24/1996 | CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 07/24/1996 | CN1127125A Medicine for hepatitis |
| 07/23/1996 | US5539128 Compounds for inhibiting leukotriene receptors as antiasmatics, antiarthritics, skin disorders, antiulcer agents or cardiovascular disorders |
| 07/23/1996 | US5539125 1-azabicyclo[3.3.0]octan derivative, salt thereof, process for the preparation of same and use thereof as hypermotility agents |
| 07/23/1996 | US5538982 Medical use for tachykinin antagonists |
| 07/23/1996 | US5538975 (-)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5yl) -(1h)-pyrimidin-2-one and derivatives; antiviral agent |
| 07/23/1996 | US5538961 Macrocyclic lactam prokinetic agents |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/23/1996 | CA1338474C Pyridoindole derivatives and processes for preparation thereof |
| 07/18/1996 | WO1996021731A2 Stabilized external guide sequences |
| 07/18/1996 | WO1996021661A1 Piperidine derivatives having tachykinin antagonist activity |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021468A2 Chemically modified interferon |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209557A1 Chemically modified interferon |
| 07/17/1996 | EP0721785A2 Delittered ranitidin preparation |
| 07/17/1996 | EP0721505A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/17/1996 | EP0721338A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 07/17/1996 | EP0721324A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 07/17/1996 | CN1126993A Magnesium omeprazole |
| 07/17/1996 | CN1126946A New pharmaceutical formulation |
| 07/17/1996 | CN1126598A External application plaster for hepatitis, hepatocirrhosis and hepatonecrosis |
| 07/17/1996 | CN1126590A Pharmaceutical compositions and a process for the preparation thereof |
| 07/17/1996 | CN1032309C 吲哚衍生物 Indole derivatives |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536736 Triazolyl-phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 07/16/1996 | US5536733 Gastrointestinal |
| 07/16/1996 | US5536718 Tricyclic benzazepine vasopressin antagonists |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | WO1996020703A1 Compounds for veterinary and medicinal applications |
| 07/11/1996 | WO1996020599A1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| 07/11/1996 | CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720609A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
| 07/10/1996 | EP0720601A1 Gastrin and cck receptor ligands |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0710267A4 Storage stable partially neutralized acid compositions and uses |
| 07/10/1996 | EP0619818B1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| 07/10/1996 | CN1126207A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 07/10/1996 | CN1126203A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 07/10/1996 | CN1126074A "Texiaoling" drug for liver disease and its prepn. method |
| 07/10/1996 | CN1032253C Process for preparation of oxalylamino acid derivatives, and their use as medicaments for inhibiting proline hydroxylase |
| 07/09/1996 | US5534530 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |
| 07/09/1996 | US5534515 Pyrrolopyridazines having gastrointestinal protective effects |
| 07/09/1996 | US5534511 Aminoalkyl benzoxazolinones and benzothiazolinones |
| 07/09/1996 | US5534505 Ursodeoxycholic acid-containing medicament in a liquid adminstration form |
| 07/09/1996 | US5534498 Trypsin inhibitors |
| 07/09/1996 | US5534493 Use of growth factor IGF-I or IGF-II |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 07/04/1996 | WO1996020197A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents |
| 07/04/1996 | WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2207653A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents |
| 07/03/1996 | EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 07/03/1996 | EP0719783A2 Phosphorylated saccharide and method for producing the same |
| 07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 07/03/1996 | EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel |
| 07/03/1996 | EP0719548A1 Gelling agent for polyethylene glycol |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719253A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 07/03/1996 | EP0719251A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
| 07/03/1996 | EP0719153A1 Inhibition of heparin-binding |
| 07/03/1996 | EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 07/03/1996 | CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/03/1996 | CN1032208C Process of preparing amides and their addin salts for medical use |
| 07/03/1996 | CN1032207C Process for preparing imidazopyrazole derivatives, witch use as analgesics and anti-inflammatory agents |
| 07/02/1996 | US5532258 Antiulcer agents |
| 07/02/1996 | US5532246 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
| 07/02/1996 | US5532235 Tricyclic benzazepine vasopressin antagonists |